Immage Biotherapeutics Corp.
IMMG
$0.00
$0.000.00%
OTC PK
| 02/28/2017 | 11/30/2016 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.16% | 3.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -97.36% | 2,595.00% | |||
| Operating Income | 97.36% | -2,595.00% | |||
| Income Before Tax | 97.36% | -2,595.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 97.36% | -2,595.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 97.36% | -2,595.00% | |||
| EBIT | 97.36% | -2,595.00% | |||
| EBITDA | 97.48% | -2,662.75% | |||
| EPS Basic | 97.32% | -2,700.00% | |||
| Normalized Basic EPS | 97.14% | -2,233.33% | |||
| EPS Diluted | 97.32% | -2,700.00% | |||
| Normalized Diluted EPS | 97.14% | -2,233.33% | |||
| Average Basic Shares Outstanding | 1.45% | 1.93% | |||
| Average Diluted Shares Outstanding | 1.45% | 1.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||